Table 7.
CDHR-NUS +99mTc-MIBI PS | SGD (126 patients) | CI 95% |
---|---|---|
Sensibility | 95% | 92–99 |
Specificity | 99% | 98–100 |
PPV | 97% | 94–100 |
NPV | 99% | 97–100 |
LR+ | 98.5 | 37.1–201.4 |
LR− | 0.05 | 0.02–0.10 |
CDHR-NUS +99mTc-MIBI PS | SGD (126 patients) | CI 95% |
---|---|---|
Sensibility | 95% | 92–99 |
Specificity | 99% | 98–100 |
PPV | 97% | 94–100 |
NPV | 99% | 97–100 |
LR+ | 98.5 | 37.1–201.4 |
LR− | 0.05 | 0.02–0.10 |